Lasertec Corporation 6920
Lasertec, Japan's most actively traded stock at a $23B cap and 17x sales, is a textbook accounting fraud — a defective EUV tool, fake fab, and looming impairment will wipe out most earnings.
Thesis
Lasertec, a once-obscure $50-100MM Japanese microcap, now sports a $23B market cap and trades at 17x sales as 'Japan's ASML' — yet its flagship ACTIS EUV mask-inspection tool is defective, its light source was secretly licensed from a tiny 12-person Russian shop called Isteq and rebadged as 'Urashima', and its 'next-generation' A300 is a cover story for a recall crisis. Scorpion Capital conducted a five-month investigation spanning 20+ expert interviews and ~20 investigator field visits, concluding Lasertec is one of Japan's largest accounting frauds, with the highest reported margins in semicap but the lowest cash conversion, inventory at 100% of revenue (triple peers), and all revenue growth since March 2023 coming from siphoning deferred-revenue 'advances'. Yokohama 'fabs' were found deserted via drone surveillance. A 65-70% impairment loss looming will exceed Olympus's, as TSMC, Intel, and Samsung abandon the tool and KLA's 2025 entry spells 'game over'.
SCQA
Lasertec is a formerly obscure Japanese semiconductor-equipment supplier that rebranded around EUV mask inspection, vaulting from a $50-100MM penny stock to a $23B market cap as 'Japan's ASML' and the country's most actively traded stock at 17x sales.
Its flagship ACTIS EUV tool is defective with a fatally flawed light source secretly licensed from a 12-person Russian shop; margins are fake, cash flow microscopic, inventory is 100% of revenue, the Yokohama fab is empty, and the A300 is a recall cover-up.
Scorpion is publicly short; investors should exit before a 65-70% write-down — a loss that will wipe out ~70% of cumulative earnings and 85% of retained earnings since the ACTIS EUV launch, exceeding Olympus's impairment.
A blow-up reminiscent of Olympus and Toshiba, with KLA's 2025 EUV-inspection entry called 'devastating', 'catastrophic', 'game over' by customers — collapsing the $23B cap back toward its pre-EUV $50-100MM range (~95%+ downside).
The three reasons
- 1
Flagship ACTIS EUV mask-inspection tool is defective with a fatally flawed Russian-sourced light source
- 2
Inventory at 100% of revenue is the highest of any semicap equipment company on earth
- 3
Yokohama 'Innovation Park' fabs are deserted per drone surveillance — the expansion is a hoax
Primary demands
- Sell Lasertec stock ahead of a 65-70% impairment charge
- Reassess inventory valuation and deferred revenue ('advances') accounting
- Investigate whether the Yokohama Innovation Park 'fabs' are operational
- Scrutinize the defective ACTIS EUV tool and the Isteq/Urashima light-source rebrand
- Recognize KLA's 2025 EUV mask-inspection launch as an existential threat
KPIs cited
Pattern membership
Precedents cited
- Olympus 2011 accounting fraud (goodwill/impairment scheme)
- Toshiba accounting scandal (fraudulent semiconductor inventory valuation)
- Enron CEO departure pattern (Okabayashi resignation parallel)
- Prior short-lived semicap monopolies that collapsed overnight
Composition what's on the 315 slides
Slide gallery ·
Notes
Landmark 334-page Scorpion Capital short report on Lasertec (TSE:6920), published June 5, 2024. Classic short-seller 'mosaic' methodology: 5-month investigation, 20+ expert interviews (ex-TSMC R&D, Intel mask VP, ASML/Cymer source experts, Isteq insider), ~20 drone-surveillance field visits to Yokohama Innovation Park. Evidence chain is unusually rich for the genre — drone photos of dust-caked HVAC inside purported 'Fab 4A' and an empty 'Fab 4B' with 'just a ladder and a few pieces of wood' are the most damning visual reveals. Heavy reliance on Olympus/Toshiba analogues to frame the fraud pattern (goodwill impairment, inventory valuation). Financial forensics are textbook: inventory bloat (100% of revenue vs. 24-31% peer median), deferred-revenue 'advances' siphoning since Mar '23, margin/FCF divergence. Quotes CEO Okabayashi on Fab 4B production capacity and contrasts with the empty interior — the core CEO-quote-contradiction moment. Uses dramatic before/after framing (penny stock → 'Japan's ASML'; ACTIS launch as inflection point for fraud). Visual craft is institutional-clean, not editorial: Avenir-style sans-serif, consistent red-underline accent, basic Capital-IQ tables and bar charts. No SOTP — it's a zero thesis, not a breakup argument. Opening Japanese proverb slide ('To hide a lie, a thousand lies are needed' / 嘘を隠すには、もっと大きな嘘が必要になる) is a memorable rhetorical framing device. No named individual author; attributed to the firm.